证券代码：300451 证券简称：创业慧康 公告编号：2025-036 创业慧康科技股份有限公司 关于聘任公司财务总监的公告 特此公告。 创业慧康科技股份有限公司 董事会 2025 年 6 月 24 日 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 创业慧康科技股份有限公司(以下简称"公司")于 2024 年 9 月 30 日召开第 八届董事会第九次会议，审议通过了《关于董事会秘书代行财务总监职责的议案》， 在公司董事会聘任新的财务总监之前，将由董事会秘书胡燕女士代行公司财务总 监职责。 近日，根据《中华人民共和国公司法》《创业慧康科技股份有限公司章程》 及相关法律法规的规定，经公司总经理提名，并经公司第八届董事会提名委员会、 审计委员会审核通过，公司于 2025 年 6 月 24 日召开了第八届董事会第十六次会 议，审议通过了《关于聘任公司财务总监的议案》。同意聘任郑奇先生（简历详 见附件）为公司财务总监，自本次董事会审议通过之日起至第八届董事会任期届 满之日止。胡燕女士将不再代行公司财务总监职责，仍继续担任公司董事会秘书。 胡燕女士在代行公司财务总监期间勤勉 ...

| 股东 名称 | 持股数量（股） | 持股比例 | 累计被冻结 数量（股） | 累计被标记 数量（股） | 合计占其 所持股份 | 合计占公 司总股本 | | --- | --- | --- | --- | --- | --- | --- | | | | | | | 比例 | 比例 | | 葛航 | 205,074,982 | 13.24% | 99,447,651 | 0 | 48.49% | 6.42% | | 合计 | 205,074,982 | 13.24% | 99,447,651 | 0 | 48.49% | 6.42% | 证券代码：300451 证券简称：创业慧康 公告编号：2025-034 创业慧康科技股份有限公司 关于股东部分股份解除冻结的公告 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 创业慧康科技股份有限公司（以下简称"公司"）于近日通过中国证券登记 结算有限责任公司深圳分公司系统查询，获悉公司 5%以上股东葛航先生持有的 5,485 万股股份已解除司法冻结，占公司总股本的 3.54%。现将具体情况公告如 下： | 股东 名称 | 是 ...

Group 1 - The DRG/DIP sector is experiencing a rise, with stocks such as Saili Medical (603716) hitting the daily limit up [1] - Other companies like Chuangying Huikang (300451), Dian Diagnostics (300244), Sichuang Medical (300078), Guoxin Health (000503), and Jiuyuan Yinhai (002777) are also seeing significant increases [1] - There is an influx of dark pool funds into these stocks, indicating strong investor interest [1]

Group 1 - The world's largest diameter underwater shield tunnel has successfully completed the Yellow River section excavation, marking a significant milestone in the construction of this project [1] - The project team has implemented innovative techniques to adapt to the unique geological conditions of the Yellow River basin, including increasing the shield machine's cutter head opening rate and installing a high-flow central flushing system [1] - The "Shanhe" shield machine has completed 1,376 rings and 2,752 meters of excavation, achieving 83% of the construction progress [1] Group 2 - Longxin Zhongke has partnered with Beihang University to launch China's first cross-satellite instant data service system based on Longxin, aimed at providing reliable navigation and communication coverage in complex environments [1] - This system is expected to support various sectors, including low-altitude economy, smart oceans, and emergency management, extending its influence to countries along the Belt and Road Initiative [1] Group 3 - Chuangye Huikang Technology Co., Ltd. has signed a cooperation agreement with Zhejiang University to establish a joint laboratory focused on AI applications in medicine, particularly centered around medical large models [1] - The laboratory will be located at Chuangye Huikang's headquarters and will concentrate on research and transformation of AI+medical innovations [1] Group 4 - Huawei is set to launch the new generation commercial tablet, the Qingyun C5, which features an 11.5-inch 120Hz full-screen display and runs on the HarmonyOS operating system [1]

Core Insights - The conference highlighted the significant digital transformation occurring in the healthcare sector, emphasizing the potential of medical AI in enhancing healthcare services [1][2] - The launch of the Huikang Cloud Hub Intelligent Agent marks a strategic advancement in healthcare information technology, integrating AI capabilities into medical business systems [2][5] Group 1: Conference Overview - The first Future Health Digital Ecosystem Conference was held on June 15, featuring the launch of Huikang's strategic product [1] - The event was co-hosted by several health organizations and included speeches from prominent figures in the healthcare sector [1] - Over 300 medical experts and industry leaders participated, discussing breakthroughs in medical AI technology and industry trends [1] Group 2: Intelligent Agent Technology - The emergence of AI Agents is transforming the interaction paradigm in healthcare information systems from "human-computer interaction" to "intelligent symbiosis" [2] - The Huikang Cloud Hub Intelligent Agent incorporates five core intelligence categories: perception, memory, planning, tools, and execution [2][4] - This intelligent agent aims to reshape healthcare operations across various dimensions, including strategy, organizational structure, and technology stack [2] Group 3: Practical Applications - The intelligent agent can convert patient information into actionable data, providing precise diagnostic and treatment recommendations in seconds [4] - In hospital management, the agent analyzes vast amounts of operational data to derive deep insights and create an intelligent management loop [4] - The intelligent agent's applications extend across clinical services, hospital operations, and public health, impacting over 50 vertical scenarios [4] Group 4: Strategic Goals - The development of a next-generation cloud intelligent HIT system is a core objective of Huikang's "Huikang Cloud 3.0" strategy [5] - The company plans to invest resources and collaborate with ecosystem partners to drive technological breakthroughs and standardization in the HIT industry [5] - The ultimate goal is to enhance the quality, efficiency, and cost-effectiveness of healthcare services, benefiting patients and healthcare professionals [5]

证券代码：300451 证券简称：创业慧康 公告编号：2025-033 创业慧康科技股份有限公司 关于完成工商变更登记的公告 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 创业慧康科技股份有限公司（以下简称"公司"）于 2025年 5月 29日召开 2024 年年度股东大会，审议通过了《关于变更注册地址并修改<公司章程>的议案》。 具 体 内 容 详 见 公 司 刊 登 在 中 国 证 监 会 指 定 信 息 披 露 网 站 巨 潮 资 讯 网 （www.cninfo.com.cn）上的相关公告。 近日，公司完成了相关工商变更登记手续，并收到浙江省市场监督管理局 的《企业法人营业执照》，变更后登记信息如下： 统一社会信用代码：9133000025393934X6 名称：创业慧康科技股份有限公司 住所：浙江省杭州市滨江区浦沿街道坚塔街 708 号 6 楼 法定代表人：张吕峥 注册资本：壹拾伍亿肆仟玖佰壹拾贰万肆仟陆佰玖拾贰元 成立时间：1997 年 12 月 10 日 经营范围：一般项目：软件开发；物联网技术研发；物联网技术服务；物联网 应用服务；物联网设备销售； ...

Industry Rating - The industry rating is maintained at "Outperform" [1] Core Insights - The report suggests that the years 2025-2026 are expected to mark the commercialization of AI Agents, driven by advancements in large model capabilities and the introduction of key players like OpenAI, Anthropic, Microsoft, and Google [2][3] - The total addressable market (TAM) for AI Agents is estimated at approximately 3.61 trillion yuan, with significant opportunities in vertical industries such as IT and finance [2][3] - AI Agents are projected to replace specific standardized roles in various sectors, with a focus on enhancing productivity and ROI for businesses [3][48] Summary by Sections Investment Rating - The report maintains a rating of "Outperform" for the industry [1] Market Potential - The total addressable market (TAM) for AI Agents is estimated at 3.61 trillion yuan, calculated based on total salary levels, replacement rates, and efficiency optimization [50][54] - The report highlights six core scenarios where AI Agents are expected to penetrate first, including coding, banking, human resources, legal, cybersecurity, and customer service [61][62] Key Industry Insights - AI Agents are anticipated to significantly impact the banking sector, with 54% of jobs having a high potential for automation, leading to an estimated TAM of 1774.32 billion yuan in this field [71][77] - In the coding sector, AI is expected to automate up to 99% of coding tasks by the end of 2025, with a TAM of approximately 4357.84 billion yuan [63][68] - The report emphasizes that AI Agents will first replace roles in high-salary, white-collar industries such as finance, IT, and law, where the ROI for AI implementation is more favorable [55][57] Company Recommendations - The report suggests monitoring companies involved in general office applications and enterprise SaaS, as well as those in vertical markets like banking, human resources, and cybersecurity [3][4]

Core Viewpoint - The announcement details a share transfer agreement involving shareholder Ge Hang, which aims to address a default in stock pledge financing through a repurchase transaction [1] Group 1: Share Transfer Agreement - Ge Hang will transfer 40 million shares of the company, representing 2.58% of the total share capital, to the Jinfu Yuan Chang Gong No. 5 Fund [1] - The transfer price is set at 3.85 yuan per share, totaling 154 million yuan (including tax) [1] - The share transfer is subject to compliance confirmation by the Shenzhen Stock Exchange before proceeding with the transfer registration at the China Securities Depository and Clearing Corporation Limited Shenzhen Branch [1]

证券代码：300451 证券简称：创业慧康 公告编号：2025-032 创业慧康科技股份有限公司 关于股东通过协议转让方式进行股票质押式回购交易违约 处置的提示性公告 股东葛航先生保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 特别提示： 1、创业慧康科技股份有限公司（以下简称"公司"）股东葛航先生（以下 简称"出让方"或"甲方"）为归还股票质押融资，与锦福源（海南）私募基金 管理合伙企业（有限合伙）（作为锦福源长弓五号私募证券投资基金管理人）（以 下简称"乙方"或"锦福源长弓五号基金"）、国元证券股份有限公司（以下简 称"国元证券"、"质权人"或"丙方"）签署了《股份转让协议》，拟通过协 议转让方式进行股票质押式回购交易违约处置，以股份转让价款偿还其在国元证 券的部分股票质押融资债务。 2、本次协议转让股份不触及要约收购。公司无控股股东、无实际控制人， 对公司生产经营、公司治理等方面不会产生影响。 3、本次股份转让所得全部价款均系用于偿还国元证券债务，受让方将在取 得深交所确认文 ...

Group 1 - The core business of the company is the construction, research, and service innovation of healthcare information technology [2] - The company offers a wide range of products including hospital information application software, public health information application software, and various cloud platforms [2] - The company has received multiple honors, including being recognized as a "China Software Integrity Demonstration Enterprise" and a "Top 100 Digital Economy Enterprise in Hangzhou" [2] Group 2 - In the first quarter of 2025, the company reported revenue of 290 million yuan, a year-on-year decrease of 22.67%, and a net loss of approximately 15.65 million yuan, a year-on-year decline of 226.60% [3] - The company's gross profit margin stands at 55.12% [3] Group 3 - As of June 5, the company's stock closed at 5.5 yuan, up 1.85%, with a latest price-to-book ratio of 1.93 and a total market capitalization of 8.52 billion yuan [1] - On June 5, the company experienced a net inflow of 17.14 million yuan in principal funds, although it has seen a total outflow of 26.15 million yuan over the past five days [1] Group 4 - The company's price-to-earnings ratio (TTM) is -42.28, while the industry average is 113.54 [4] - The company's market capitalization is 8.52 billion yuan, compared to the industry median of 5.70 billion yuan [4]